RELATED: GenScript Biotech has opened a supply, manufacturing and research site in Nanjing and plans a commercial-scale version in Zhenjiang. The company is also working on an oral drug that it hopes will be approved by the U.S. Food and Drug Administration for use against cancer or other diseases. It said the commercial facility would be the first and largest such site in China which researched and developed gene and cell therapies and antibody drugs. The larger site will also cover plasmid and virus manufacture.
GenScript Biotech has opened a supply, manufacturing and research site in Nanjing and plans a commercial-scale version in Zhenjiang. The company is also working on an oral drug that it hopes will be approved by the U.S. Food and Drug Administration for use against cancer or other diseases. It said the commercial facility would be the first and largest such site in China which researched and developed gene and cell therapies and antibody drugs. The larger site will also cover plasmid and virus manufacture.